Regulation of the Transient Outward K+ Current by Ca2+/Calmodulin-Dependent Protein Kinases II in Human Atrial Myocytes

S Tessier, P Karczewski, EG Krause… - Circulation …, 1999 - Am Heart Assoc
S Tessier, P Karczewski, EG Krause, Y Pansard, C Acar, M Lang-Lazdunski, JJ Mercadier
Circulation research, 1999Am Heart Assoc
Ca2+/calmodulin-dependent protein kinases II (CaMKII) have important functions in
regulating cardiac excitability and contractility. In the present study, we examined whether
CaMKII regulated the transient outward K+ current (I to) in whole-cell patch-clamped human
atrial myocytes. We found that a specific CaMKII inhibitor, KN-93 (20 μmol/L), but not its
inactive analog, KN-92, accelerated the inactivation of I to (τfast: 66.9±4.4 versus 43.0±4.4
ms, n= 35; P< 0.0001) and inhibited its maintained component (at+ 60 mV, 4.9±0.4 versus …
Abstract
—Ca2+/calmodulin-dependent protein kinases II (CaMKII) have important functions in regulating cardiac excitability and contractility. In the present study, we examined whether CaMKII regulated the transient outward K+ current (Ito) in whole-cell patch-clamped human atrial myocytes. We found that a specific CaMKII inhibitor, KN-93 (20 μmol/L), but not its inactive analog, KN-92, accelerated the inactivation of Itofast: 66.9±4.4 versus 43.0±4.4 ms, n=35; P<0.0001) and inhibited its maintained component (at +60 mV, 4.9±0.4 versus 2.8±0.4 pA/pF, n=35; P<0.0001), leading to an increase in the extent of its inactivation. Similar effects were observed by dialyzing cells with a peptide corresponding to CaMKII residues 281 to 309 or with autocamtide-2–related inhibitory peptide and by external application of the calmodulin inhibitor calmidazolium, which also suppressed the effects of KN-93. Furthermore, the phosphatase inhibitor okadaic acid (500 nmol/L) slowed Ito inactivation, increased Isus, and inhibited the effects of KN-93. Changes in [Ca2+]i by dialyzing cells with ≈30 nmol/L Ca2+ or by using the fast Ca2+ buffer BAPTA had opposite effects on Ito. In BAPTA-loaded myocytes, Ito was less sensitive to KN-93. In myocytes from patients in chronic atrial fibrillation, characterized by a prominent Isus, KN-93 still increased the extent of inactivation of Ito. Western blot analysis of atrial samples showed that δ-CaMKII expression was enhanced during chronic atrial fibrillation. In conclusion, CaMKII control the extent of inactivation of Ito in human atrial myocytes, a process that could contribute to Ito alterations observed during chronic atrial fibrillation.
Am Heart Assoc